Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)
- PMID: 2817859
- PMCID: PMC172714
- DOI: 10.1128/AAC.33.9.1617
Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)
Abstract
A total of 144 clinical isolates of Acinetobacter species, i.e., A. baumannii (n = 60), genospecies 3 (n = 48), A. haemolyticus (n = 12), and genospecies 6 (n = 24), were examined comparatively with the agar dilution method of the National Committee for Clinical Laboratory Standards for susceptibility to 25 antimicrobial drugs. Only minor species differences were noted.
Similar articles
-
Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-Year Observation period: serotyping, macrorestriction analysis of Genomic DNA and antibiotic susceptibilities.Chemotherapy. 2000 Jul-Aug;46(4):282-92. doi: 10.1159/000007300. Chemotherapy. 2000. PMID: 10859434
-
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.Diagn Microbiol Infect Dis. 2011 Jul;70(3):380-6. doi: 10.1016/j.diagmicrobio.2011.03.003. Epub 2011 May 10. Diagn Microbiol Infect Dis. 2011. PMID: 21558048
-
Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.Int J Antimicrob Agents. 2010 May;35(5):439-43. doi: 10.1016/j.ijantimicag.2009.11.020. Epub 2010 Jan 27. Int J Antimicrob Agents. 2010. PMID: 20106635
-
Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates.J Clin Microbiol. 2007 Mar;45(3):902-5. doi: 10.1128/JCM.01573-06. Epub 2006 Dec 27. J Clin Microbiol. 2007. PMID: 17192417 Free PMC article.
-
The Acinetobacter baumannii group: a systemic review.World J Emerg Med. 2013;4(3):169-74. doi: 10.5847/wjem.j.issn.1920-8642.2013.03.002. World J Emerg Med. 2013. PMID: 25215113 Free PMC article. Review.
Cited by
-
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.Clin Microbiol Rev. 1996 Apr;9(2):148-65. doi: 10.1128/CMR.9.2.148. Clin Microbiol Rev. 1996. PMID: 8964033 Free PMC article. Review. No abstract available.
-
Genetic diversity and clonal relationships of Acinetobacter baumannii strains isolated in a neonatal ward: epidemiological investigations by allozyme, whole-cell protein and antibiotic resistance analysis.Epidemiol Infect. 1993 Dec;111(3):491-8. doi: 10.1017/s0950268800057228. Epidemiol Infect. 1993. PMID: 8270009 Free PMC article.
-
Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia.J Clin Microbiol. 2002 Dec;40(12):4571-5. doi: 10.1128/JCM.40.12.4571-4575.2002. J Clin Microbiol. 2002. PMID: 12454154 Free PMC article.
-
In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.Antimicrob Agents Chemother. 1993 Jan;37(1):138-41. doi: 10.1128/AAC.37.1.138. Antimicrob Agents Chemother. 1993. PMID: 8431011 Free PMC article.
-
Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.Antimicrob Agents Chemother. 1995 May;39(5):1201-3. doi: 10.1128/AAC.39.5.1201. Antimicrob Agents Chemother. 1995. PMID: 7625818 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases